Oliver Brahmst is White & Case's Global Co-Head of Private Equity. His practice focuses on domestic and cross-border acquisitions and divestitures, including joint ventures and equity co-investments.
Oliver has built up a significant track record in the resolution of complex cross-border transactions, having worked on some of the most innovative and exciting deals of the last ten years.
Often working across multiple jurisdictions, Oliver has advised on high-profile transactions and taken a major role in such landmark deals as the representation of CVC Capital Partners in leading a consortium in their acquisition of a controlling stake in Alvogen, and the representation of Nordic Capital and Avista Capital Partners' in their US$4.1 billion acquisition of the ConvaTec business unit from Bristol-Myers Squibb. Requiring the coordination of our Doha, London, Brussels and Paris offices alongside Oliver’s team in New York, Oliver’s recent deals also include the representation of Qatar Investment Authority and Kingdom Holding Company of Saudi Arabia in the US$2.9 billion stock-and-cash sale of FRHI, the Canada-based parent company of luxury hotel brands Fairmont, Raffles and Swissôtel, to AccorHotels.
Oliver regularly leads legal teams in delivering innovative solutions to seemingly intractable challenges, such as his representation of Pilot Travel Centers during their acquisition of Flying J's core travel plaza and truck stop businesses. The deal took place at a critical point in Flying J's bankruptcy and, in the face of immense time constraints, Oliver and his colleagues created a framework for a transaction that simultaneously advanced Pilot Travel Centers' objectives and gained the support of the bankruptcy court and of Flying J's creditors' committee. The deal was described by The M&A Advisor as a "deal of the decade."
As a mark of the esteem in which he is held in the financial and legal community, Oliver is named as a leading individual for M&A and Private Equity in Chambers, Euromoney and The Legal 500.
Brookfield Infrastructure, 2019
Oliver represented a consortium composed of Brookfield Infrastructure, its institutional partners and GIC, Singapore's sovereign wealth fund, on the US$8.4 billion acquisition of Genesee & Wyoming Inc. (NYSE:GWR), a freight railroad owner and operator based in the United States.
Investcorp International Inc., 2019
Oliver represented Investcorp Inc. in its acquisition of Multivision, LLC, an IT solutions and training provider.
CVC Capital Partners, 2018
Oliver represented CVC Capital Partners in the US$1.8 billion acquisition of ConvergeOne Holdings, Inc. (Nasdaq: CVON), a leading global IT and managed services provider of collaboration and technology solutions.
CVC Capital Partners, 2018
Oliver represented CVC Capital Partners in its acquisition of a majority equity stake in UnitedLex, a leading alternative legal services provider.
Brookfield Asset Management, 2018
Oliver represented Brookfield Asset Management in its CAD$4.3 billion acquisition of Enercare Inc., one of North America's largest home and commercial services companies.
Brookfield Asset Management, 2018
Oliver represented Brookfield Asset Management as 50 percent equity investor with Digital Realty Trust in its US$1.8 billion acquisition of Ascenty from Great Hill Partners.
CVC Capital Partners, 2018
Oliver represented CVC Capital Partners in its acquisition of OANDA Global Corporation, a global online retail trading platform, currency data and analytics company.
Oliver represented Investcorp, in its majority investment in ICR, LLC, a leading strategic communications and advisory company.
FCX Performance, Inc., 2018
Oliver represented FCX Performance, Inc., a portfolio company of Harvest Partners, in its approximately US$768 million sale to Applied Industrial Technologies, Inc. (NYSE: AIT).
CVC Capital Partners, 2017
Oliver represented CVC Capital Partners in its US$1.425 billion acquisition of beauty and personal care products company PDC Brands from Yellow Wood Partners.
Berkshire Hathaway investment in Pilot Flying J, 2017
Oliver represented Pilot Flying J, the largest operator of travel centers in North America, and its shareholders, the Haslam Family, in the investment in a significant minority stake by Berkshire Hathaway.
Oliver represented Odebrecht S.A. in its US$1.39 billion sale of the 456 MW Chaglla hydroelectric power plant in Peru to a consortium headed by China Three Gorges Corp.
Oliver represented BHI Investments, a leading specialty energy services company and a portfolio company of Harvest Partners, in its sale to AE Industrial Partners.
Oliver represented Certares LP, in its acquisition of substantially all Guardian Alarm, a leading provider of alarm and security guard services and in its acquisition of Guardian Medical Monitoring, a leading provider of medical monitoring services throughout the United States.
Investcorp investment in AlixPartners, 2016
Oliver represented Investcorp in its co-acquisition of CVC Capital Partners' ownership stake in AlixPartners.
China Three Gorges US$1.2 billion acquisition in Brazil, 2016
Oliver represented China Three Gorges Corporation in its US$1.2 billion acquisition of Duke Energy's assets in Brazil.
Qatar Investment Authority transactions, 2015 and 2016
Oliver represented Qatar Investment Authority and Kingdom Holding Company of Saudi Arabia, in the US$2.9 billion sale of FRHI, the parent company of luxury hotel brands Fairmont, Raffles and Swissôtel, to AccorHotels. Oliver also represented QIA in the purchase of shares in Empire State Realty Trust, Inc. (ESRT) (NYSE:ESRT) through a private offering worth approximately US$622 million.
Hikma Pharmaceuticals PLC US$2.65 billion acquisition of generic drugs businesses, 2015
Oliver advised Hikma Pharmaceuticals PLC in its US$2.65 billion acquisition of the US-based generic drugs businesses, Roxane Laboratories and Boehringer Ingelheim Roxane, from German drug maker Boehringer Ingelheim.
CVC Capital Partners acquisition of a controlling stake in Alvogen, 2015
Oliver advised CVC Capital Partners in leading a consortium including Temasek Holdings and Vatera Healthcare Partners in their acquisition of a controlling stake in Alvogen, a leading generic pharmaceuticals company. The transaction was named "Cross-Border Life Sciences and Pharmaceutical Deal of the Year" by the M&A Advisor (April 2016). Oliver represented Alvogen in its subsequent acquisition of County Line Pharmaceuticals LLC, a specialty generic pharmaceutical company based in Wisconsin.
GDF Suez's sale of power assets in Latin America, 2014
Oliver represented GDF Suez S.A., in the US$840 million sale of power assets in Panama and Costa Rica to Celsia S.A. E.S.P., one of Colombia's largest power generators. This transaction was named "Cross-border deal of the Year" by M&A Advisor, 2015.
Electronic Funds Source's Sale, 2014
Oliver represented Electronic Funds Source LLC, a leader in innovative corporate payment solutions, in its sale to an affiliate of Warburg Pincus, LLC.
Univar's acquisitions of Magnablend Holdings and Basic Chemical Solutions, 2013 and 2010
Oliver acted for Univar Inc., a leading global distributor of industrial and specialty chemicals in more than 100 countries, in its acquisition of Magnablend Holdings, Inc., and in its acquisition of Basic Chemical Solutions, LLC, a leading global distributor and trader of commodity chemicals.
Pilot Flying J's acquisition of a controlling interest in Maxum Petroleum, 2012
Oliver advised Pilot Flying J, in its acquisition of a controlling interest in Maxum Petroleum, Inc., a leading independent energy logistics company.
Harvest Partners transactions, 2003-2017
Oliver represented Harvest Partners and its portfolio companies in a large number of deals, including the US$1.3 billion sale of Associated Materials to Hellman & Friedman LLC; the acquisition of Material Handling Services; and the joint acquisition, with Audax Private Equity, of CWD Holdings Corp., a distributor of auto parts.
Debt Financing Risk Allocation in US Sponsor-Led Acquisitions: A Short History and Primer, Euromoney's Banking Finance and Transactional Expert Guide, 2012 (co-author with Matthew Hendy)
Leading Lawyer for Leveraged Buyouts and Private Equity Law, The Best Lawyers in America 2019
Leading Lawyer for M&A and Private Equity in the United States, Euromoney's M&A and Private Equity Expert Guide, 2019
Leading Individual for Private Equity, Chambers Global, 2019
Leading Individual for M&A, Who's Who Legal, 2019
Leading Individual for M&A and Private Equity, Chambers USA, 2019
Recognized Individual for M&A Large Deals and Private Equity Buyouts, Legal 500 US, 2019
Named "M&A Legal Advisor of the Year", M&A Advisor, 2015